Indivior (United States)
Institution data
| Type | COMPANY (active) |
|---|---|
| Country | Chesterfield, US |
| Works | 4 |
| Researchers | 8 |
| Coverage | 2024 - 2026 |
| ROR | 04drzaz56 |
| GRID | grid.504165.3 |
| OpenAlex | I4210146161 |
| Website | http://indivior.com |
| Also known as | Indivior (United States) |
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder
A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy
Re
Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder
A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy
Re
Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest
Comparison of intranasal naloxone and intranasal nalmefene in a translational model assessing the impact of synthetic opioid overdose on respiratory depression and cardiac arrest
A Discrete-Choice Experiment to Assess Patient Preferences for Long-Acting Injectable Treatments in Opioid Use Disorder in Australia, Finland, Germany, and Italy
Re
Association between extended-release buprenorphine adherence and reduced healthcare costs among insured patients with opioid use disorder
| ARTICLE | 4 |
|---|
| 2026 | 1 |
|---|---|
| 2025 | 2 |
| 2024 | 1 |